Gram-Negative
Currently in Regulatory Process

Gram-Negative Rods

Currently under regulatory review
Anticipated Summer 2019

The iCubate iC-GN Assay™ is a multiplexed, in vitro diagnostic test for the rapid detection and identification of potentially pathogenic gram negative bacteria, which may cause bloodstream infection (BSI).  Traditional culture techniques may require 2-4 days to identify both the causative organism and resistance profile, resulting in delayed treatment and increased costs.  The iC-GN Assay™ provides bacterial identification and resistance determination from positive blood cultures up to 48 hours faster than conventional methods, improving time to treatment and patient outcomes. The iC-GN Assay™ detects eight of the most common gram negative organisms associated with BSI as well as three clinically significant resistance markers

Bacterial Genera and Species Resistance Markers
Acinetobacter baumannii complex

Enterobacter cloacae complex

Escherichia coli

Klebsiella oxytoca

Klebsiella pneumoniae

Pseudomonas aeruginosa

Proteus species

Serratia marcescens

KPC- carbapenemase

NDM- carbapenemase

CTX-M group 1- extended spectrum β-lactamase

For research use only

The iCubate® system is the cost-effective molecular diagnostic solution providing clinical microbiology labs rapid syndromic testing for infectious diseases, leading to better care sooner.

Subscribe to Newsletter

Join the iCubate community for the latest updates!